Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junya Kanda

Showing results (301-310 of 390) with videos related to

Pageof 39
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2015
High Incidence of Afebrile Bloodstream Infection Detected by Surveillance Blood Culture in Patients on Corticosteroid Therapy after Allogeneic Hematopoietic Stem Cell TransplantationKazuaki Kameda, Shun-Ichi Kimura, Yu Akahoshi, et al.
Transplantation and Cellular Therapy|February 22, 2026
Can cord blood unit selection improve outcomes after single-unit unrelated cord blood transplantation for non-remission acute myeloid leukemia?Takaaki Konuma, Yoshimitsu Shimomura, Satoshi Yamasaki, et al.
Leukemia|March 29, 2022
Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITLKazuaki Kameda, Shinichi Kako, Sung-Won Kim, et al.
The Journal of Infection|March 7, 2015
False-positive Aspergillus galactomannan and its kinetics in allogeneic hematopoietic stem cell transplantationShun-Ichi Kimura, Yu Akahoshi, Hirofumi Nakano, et al.
Hematology (Amsterdam, Netherlands)|April 29, 2025
Insights into very elderly multiple myeloma treatment from Kansai Myeloma ForumYusuke Okayama, Teruhito Takakuwa, Yuji Shimura, et al.
Ejhaem|August 11, 2025
Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCTTakashi Toya, Yujiro Nakajima, Konan Hara, et al.
Transplantation|February 14, 2025
Impact of HLA Epitope Matching on Outcomes in Haploidentical HSCT With Distinct GVHD ProphylaxesMakoto Iwasaki, Junya Kanda, Hidenori Tanaka, et al.
Transplantation and Cellular Therapy|July 3, 2024
Real-World Outcomes of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Japan: Retrospective Analysis of the Transplant Registry Unified Management Program RegistryJunya Kanda, Takaya Mitsuyoshi, Masatoshi Sakurai, et al.
Blood Advances|January 15, 2026
GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: a nationwide Japanese cohort studySatoshi Yamasaki, Masamitsu Yanada, Shohei Mizuno, et al.
British Journal of Haematology|October 19, 2023
The prognosis and risk factors for patients with complex karyotype myelodysplastic syndrome undergoing allogeneic haematopoietic stem cell transplantationYoshimitsu Shimomura, Sho Komukai, Tetsuhisa Kitamura, et al.
Pageof 39

Showing results (301-310 of 390) with videos related to

Sort By:
Pageof 39
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2015
High Incidence of Afebrile Bloodstream Infection Detected by Surveillance Blood Culture in Patients on Corticosteroid Therapy after Allogeneic Hematopoietic Stem Cell TransplantationKazuaki Kameda, Shun-Ichi Kimura, Yu Akahoshi, et al.
Transplantation and Cellular Therapy|February 22, 2026
Can cord blood unit selection improve outcomes after single-unit unrelated cord blood transplantation for non-remission acute myeloid leukemia?Takaaki Konuma, Yoshimitsu Shimomura, Satoshi Yamasaki, et al.
Leukemia|March 29, 2022
Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITLKazuaki Kameda, Shinichi Kako, Sung-Won Kim, et al.
The Journal of Infection|March 7, 2015
False-positive Aspergillus galactomannan and its kinetics in allogeneic hematopoietic stem cell transplantationShun-Ichi Kimura, Yu Akahoshi, Hirofumi Nakano, et al.
Hematology (Amsterdam, Netherlands)|April 29, 2025
Insights into very elderly multiple myeloma treatment from Kansai Myeloma ForumYusuke Okayama, Teruhito Takakuwa, Yuji Shimura, et al.
Ejhaem|August 11, 2025
Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCTTakashi Toya, Yujiro Nakajima, Konan Hara, et al.
Transplantation|February 14, 2025
Impact of HLA Epitope Matching on Outcomes in Haploidentical HSCT With Distinct GVHD ProphylaxesMakoto Iwasaki, Junya Kanda, Hidenori Tanaka, et al.
Transplantation and Cellular Therapy|July 3, 2024
Real-World Outcomes of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Japan: Retrospective Analysis of the Transplant Registry Unified Management Program RegistryJunya Kanda, Takaya Mitsuyoshi, Masatoshi Sakurai, et al.
Blood Advances|January 15, 2026
GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: a nationwide Japanese cohort studySatoshi Yamasaki, Masamitsu Yanada, Shohei Mizuno, et al.
British Journal of Haematology|October 19, 2023
The prognosis and risk factors for patients with complex karyotype myelodysplastic syndrome undergoing allogeneic haematopoietic stem cell transplantationYoshimitsu Shimomura, Sho Komukai, Tetsuhisa Kitamura, et al.
Pageof 39